NBC Securities Inc. increased its stake in ARK Genomic Revolution ETF by 13.6% during the fourth quarter, according to HoldingsChannel. The fund now owns 3,525 shares of the company’s stock, valued at $115,000. Other hedge funds, such as Park Avenue Securities LLC and Allworth Financial LP, have also adjusted their holdings of the stock. Wealthfront Advisers LLC and Banque Pictet & Cie SA are among the other firms that have increased their holdings in ARK Genomic Revolution ETF.
ARKG stock opened at $26.51 on Friday, with a 50-day simple moving average of $26.41 and a two-hundred day simple moving average of $28.40. The ARK Genomic Revolution ETF is an actively managed fund that focuses on companies in the genomics industry. Launched on Oct 31, 2014, ARKG is managed by ARK.
For more information on hedge fund holdings and insider trades for ARK Genomic Revolution ETF, visit HoldingsChannel.com. Stay informed with the latest news and analyst ratings by signing up for MarketBeat.com’s daily email newsletter.